Flow-volume curve analysis for predicting recurrence after endoscopic dilation of airway stenosis by Fiorelli, Alfonso et al.
Accepted Manuscript
Flow-Volume Curve Analysis For Predicting Recurrence After Endoscopic Dilation Of
Airway Stenosis
Alfonso Fiorelli, MD, PhD, Camilla Poggi, MD, Nicoletta Ardò, MD, Gaetana Messina,
MD, Claudio Andreetti, MD, Federico Venuta, MD, Erino Angelo Rendina, MD,
Mario Santini, MD, Michele Loizzi, MD, Nicola Serra, PhD, Francesco Sollitto, MD,
Domenico Loizzi, MD
PII: S0003-4975(19)30329-7
DOI: https://doi.org/10.1016/j.athoracsur.2019.01.075
Reference: ATS 32402
To appear in: The Annals of Thoracic Surgery
Received Date: 9 August 2018
Revised Date: 23 December 2018
Accepted Date: 29 January 2019
Please cite this article as: Fiorelli A, Poggi C, Ardò N, Messina G, Andreetti C, Venuta F, Rendina EA,
Santini M, Loizzi M, Serra N, Sollitto F, Loizzi D, Flow-Volume Curve Analysis For Predicting Recurrence
After Endoscopic Dilation Of Airway Stenosis, The Annals of Thoracic Surgery (2019), doi: https://
doi.org/10.1016/j.athoracsur.2019.01.075.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Flow-Volume Curve Analysis For Predicting Recurrence After Endoscopic 
Dilation Of Airway Stenosis 
Running title: Flow-volume curve to follow re-stenosis 
Alfonso Fiorelli1, MD, PhD, Camilla Poggi2, MD, Nicoletta Ardò3, MD, Gaetana Messina1, MD, 
Claudio Andreetti4, MD,  Federico Venuta2, MD, Erino Angelo Rendina4, MD, Mario Santini1, MD, 
Michele Loizzi5, MD, Nicola Serra6, PhD, Francesco Sollitto3, MD, Domenico Loizzi3, MD  
 
1Thoracic Surgery Unit, University Campania “Luigi Vanvitelli”, Naples, Italy; 2Thoracic Surgery 
Unit, University La Sapienza, Policlinico Hospital, Rome, Italy;  3Thoracic Surgery Unit, University 
of Foggia, Foggia, Italy; 4Thoracic Surgery Unit, University La Sapienza, Sant’Andrea Hospital, 
Rome, Italy; 5Thoracic Surgery Unit, University of Bari, Bari, Italy; 6Statistic Unit - Department of 
Public Health,University of Federico II, Naples, Italy.  
 
 
 
Word Count:  4.383 
Key words: upper airway stenosis, flow-volume curve, endoscopic treatment   
 
 
Corresponding Author: 
Alfonso Fiorelli MD, PhD 
Thoracic Surgery Unit,   
UniversitàdegliStudidella Campania “Luigi Vanvitelli” 
Piazza Miraglia, 2 
I-80138 Naples, Italy 
Email: alfonso.fiorelli@unicampania.it 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
ABSTRACT 
BACKGROUND: The flow-volume curve is a simple test for diagnosing upper airway obstruction.  
We evaluated its use to predict recurrence in patients undergoing endoscopic dilation for treatment 
of benign upper airway stenosis.  
 
METHODS: The data of 89 consecutive patients undergoing endoscopic dilation of simple upper 
airway stenosis were retrospectively reviewed. Morphological distortion of flow-volume loop 
(visual analysis) and quantitative criteria including MEF50%/MIF50%<0.3 or > 1.0; FEV1/MEF>10; 
and FEV1/FEV0.5>1.5 were considered as predictive of recurrence. In all cases, the recurrence was 
confirmed by radiological and/or bronchoscopic findings. The sensitivity, specificity, PPV, NPV, 
and accuracy of visual, quantitative and aggregate criteria for detecting recurrence were computed 
and compared.     
 
RESULTS: Of89 patients treated, 27 (30%) had a recurrence. Visual analysis presented a 
sensitivity, specificity, PPV, NPV, and accuracy of 63%; 83.9%; 63%; and 83.9%, and 77.5% 
respectively. Among the quantitative criterion, the MEF50%/MIF50% was the most accurate 
having a sensitivity, specificity, PPV, NPV, and accuracy of 77.8%; 79%; 61.8%; and 89.1%, and 
78.7% respectively. Aggregate criterion presented the best yield compared to other criteria in terms 
of sensitivity (81.5%), specificity (91.9%), PPV (81.5%), NPV (91.9%), and accuracy (88.8%).  
 
CONCLUSIONS: The flow-volume curve is a simple and non-invasive method to follow patients 
undergoing endoscopic dilation of upper airway stenosis. Morphological changes in the flow-
volume loop and in the MEF50%/MIF50% ratio are suggestive of recurrence and guide the 
physician to implement the follow-up with further diagnostic (non)invasive exams. 
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Endoscopy is a palliative treatment of upper airway obstruction (UAO) in patients unfit for surgery. 
Stenoses  less than 1 cm in length, without cartilaginous involvement or tracheomalacia are defined 
as simple, and generally treated with radial cuts and mechanical dilation [1]. However, they can 
recur, and needs additional treatments. Since many of the patients who recur present symptoms at 
rest when narrowing is marked (≤ 6 mm) [2], to early predict re-stenosis is desirable to avoid 
emergent treatment. Chest High Resolution Computed Tomography (HRCT) scan and 
bronchoscopy follow any progression of narrowing process, but they remain expensive and invasive 
methods. The flow-volume curve is a simple and non-invasive method that graphically records 
inspiration and expiration flows (on the y-axis) against volume (on the x-axis) obtained while 
patient performs maximal forced inspiratory and expiratory maneuvers. Miller et Hyatt [3] defined 
three distinct flattenings of curve depending on whether (i) the stenosis was fixed (plateau on 
inspiratory and expiratory phase of the curve), (ii) variable intrathoracic (plateau on expiratory 
phase of the curve), or (iii) variable extrathoracic (plateau on inspiratory phase of the curve). 
Despite flow-volume curve has been used for decades to assess UAO [4,5,6], its effectiveness for 
routine follow-up of patients with UAO undergoing endoscopic treatment remains unclear. Yet, in 
the years some authors [6,7,8,9] have questioned the low sensitivity of morphological distortion of 
curve to diagnosis stenosis.   
Thus, in this study we aimed to evaluate the flow-volume curve as a surveillance tool in 
patients undergoing endoscopic treatment of UAO and to compare the accuracy of visual and 
quantitative criteria of the curve to detect recurrence.   
 
MATERIAL AND METHODS 
Study Design 
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It was a retrospective multi centers study including all consecutive patients undergoing endoscopic 
treatment of benign UAO between January 2013-January 2017. Data were extracted by prospective 
database of each participating centers.  Patients (i) with benign UAO unfit for surgery and 
undergoing endoscopic dilation; (ii) able to undergo flow-volume curve measurement; and (iii) with 
complete follow-up for at least 12 months were included. Patients (i) treated with stent insertion as 
first approach; (ii)  not performing flow-volume curve analysis before and after treatment; and (iii) 
with incomplete follow-up were excluded.   
We supposed that flow-volume curve could be a valuable method to predict a re-stenosis 
after endoscopic dilation. To test it, we evaluated the alteration of visual, quantitative and aggregate 
criteria of curve in relation to recurrence (dependent variable) and then compared the accuracy of 
each criterion to identify the most accurate. The flow-volume curves were evaluated by two 
different physicians who were blinded to the results of follow-up. Discordant results were resolved 
by a consensus with a third reader. The study design was approved by Local Ethics Committees of 
University "Luigi Vanvitelli", Naples, Italy, (approval number: 684/18) the coordinator center of 
the study, and then by each participating center. All patients gave a written informed consent for the 
treatment of UAO and the follow-up exams.   
 
Study population 
Before treatment, all patients performed standard exams including flow-volume curve 
measurement, chest  HRCT and bronchoscopy. The endoscopic treatment was performed in 
operating room with rigid bronchoscopy. Being simple stenosis, in all cases mucosal sparring 
technique was performed with radial incisions using scissors or laser, according to the center's 
preference, followed by dilation with balloon or rigid scope [1]. All patients were then followed 
with flow-volume measurements, chest CT, and bronchoscopy (if indicated) at 1, 3, 6, 9 and 12 
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months from the procedure. Patients who were free of symptoms for at least 12 months after the 
procedure were considered cured.  In patients with suspicion of restenosis, follow-up was 
implement, and the measurements were performed every 4-6 weeks. In all cases, restenosis was 
documented by chest CT scan and confirmed by bronchoscopy.   
 
Flow-Volume Curve Measurement 
The flow-volume curve was measured by expert technicians of each participating center with a 
previously calibrated plethysmograph. All spirometries were performed in accordance with ATS 
standards [5], and included a standard forced maximal exhalation, followed by a forced maximal 
inhalation. The maximum flow-volume curves were plotted on x-y axes: the flow was measured at 
the mouth and the volume was obtained by integration of the flow. Three such maneuvers were 
performed and the best effort based on Forced Vital Capacity (FVC) and on Forced Expiratory 
Volume In The First 1 Second (FEV1) was selected by computer for the analysis.   
Visual Criteria: The expiratory and inspiratory flow volume curves were reported from the best 
expiratory and inspiratory curves, respectively, which were those selected also for quantitative 
analysis. Visual alteration of loop were differentiated in three groups according to the classification 
of Miller et Hyatt [3]: (i) flattening on inspiratory and expiratory phase (fixed stenosis); (ii) 
flattening on the inspiratory phase (variable extra-thoracic stenosis); and (iii) flattening on the 
expiratory phase (variable intra-thoracic stenosis)  
Quantitative criteria: based on previous experiences [3,7,8], the following quantitative criteria to 
predict the restenosis were evaluated:   
• Maximal Expiratory Flow Rate At 50% Of The Vital Capacity/ Maximal Inspiratory Flow 
Rate At 50% Of The Vital Capacity (MEF50%/MIF50%): <0.30 or >1 (Miller et Hyatt 
index [3]) 
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• Forced Expiratory Volume in the first 1 second/Maximal Expiratory flow (FEV1/MEF) > 10 
ml/L/min (Empey index [7]) 
• Forced Expiratory Volume In The First 1 Second/ Forced Expiratory Volume In The First 
0.5 second (FEV1/FEV0.5) > 1.5 (Rotman index [8]). 
 
Aggregate Criterion: The quantitative criterion with the first-highest accuracy was associated to 
visual criterion to generate aggregate criterion. When both criteria were negative or positive, the 
aggregate criterion was considered as negative or positive, respectively; in cases of discordant 
results (one criterion negative and the other positive), to establish the correct response we also 
considered  the quantitative criterion with the second-highest accuracy. Since all criteria were 
described such as dichotomous variables (1=positive, 0=negative), in all cases the aggregate 
criterion was obtained using a mathematical model based on Boolean algebra [9], defined by one of 
the authors (N.S.): 
F= A x B + C x (A + B) 
                                             
where: F=Aggregate criterion,  A=Visual criteria,  B=Quantitative criterion with the first-highest   
accuracy, and  C=Quantitative criterion with the second-highest accuracy. 
  
Statistical Analysis  
Data were expressed as mean ± Standard Deviation (SD) for continuous variables; and as absolute 
number and percentage for categorical variables. Significant difference between two means was 
evaluated by the Student's t-test. Sensitivity, specificity, Positive Predictive Value (PPV), Negative 
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Predictive Value (NPV) and diagnostic accuracy of visual, quantitative, and aggregate criteria 
(independent variables) for predicting recurrence (dependent variable) were computed in a standard 
manner. To compare the diagnostic yield of each criterion, the multiple comparison with chi-square 
test followed by Z-test (post-hoc test) were performed. A value of p<0.05 was considered 
statistically significant. MedCalc statistical software (Version 12.3, Broekstraat 52;Mariakerke, 
Belgium) was used for this analysis. 
 
RESULTS 
In the study period, 285 patients with benign tracheal stenosis were endoscopically treated. Of 
these, 196 patients were excluded due to the stent insertion after dilation (n=101) or lack of 
available data on flow-volume curves (n=95). Thus, 89 patients were included in the analysis (Table 
1). The mean age was 73±6.9 year-old. The main cause of stenosis was post-intubation (57%). 
Cardiac disease (44%), cerebral disease (31%), respiratory disease (22%) and drug abuse (3%) were 
the main comorbidities that contraindicated surgery. In all cases, the stenosis was simple with a 
length of 8±1.3mm, distance from vocal folds of 27±3.9mm, and diameter of 6±3.7mm that reduced 
≥ 75% the tracheal lumen.  After dilation, the airway diameter  significantly increased (from 6±3.7 
mm to 14±6.7 mm; p=0.0003) without any complications. In  27 (30%) patients the stenosis 
recurred 7±4.3 months later. Of these, 19/27 (70%) presented dyspnea at rest and stridor (airway 
diameter: 6.5±1.3mm), while 8/27 (30%) had dyspnea at mild-moderate effort (airway diameter: 
8.9±2.7mm). They were re-treated with endoscopic dilation alone (n=15),  dilation followed by  
stent insertion (n=10), and surgery (n=2).        
 
Visual Analysis Of Flow-Volume Curve 
Before dilation, the loop showed a flattening (i) on inspiratory and expiratory phase in 27 (30%) 
patients (fixed stenosis); (ii) on inspiratory phase in 35 (39%) (variable extrathoracic stenosis); and 
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(iii) on expiratory phase in 15 (17%) (variable intrathoracic stenosis). The remaining 12 (14%) 
patients presented aspecific changes as absence, truncate inspiratory loop or biphasic expiratory 
loop. Examples are reported in Figure 1.  
 
Patients with recurrence (n=27): After dilation, visual analysis correctly identified the recurrence 
in 17 (63%) patients (true positive results), and in the most of cases (15 of 17; 88%) the flattening 
was suggestive of fixed stenosis. In all cases, a mild flattening was present 3 months after dilation, 
when clinical symptoms are not present. Then, the flattening become more evident at 4, 5, 6 months 
of follow-up in correlation with the reduction of tracheal diameter seen on HRCT scan and 
bronchoscopy. Finally, it was well marked concurrent with dyspnea at rest. An example is reported 
in Figure 2.  In 10 (37%) patients, no alteration  (n=8) or aspecific alterations of the loop (n=2) were 
observed (false negative results); of these, 8 presented dyspnea at mild-moderate effort.      
 
Patients without recurrence (n=62): Among 62 patients without recurrence, in 52 (83.9%) cases an 
improvement of the loop was observed and maintained for the entire follow-up (true negative 
results). They were followed 1, 3, 6, 9, 12 months, and no increase of measurements was applied 
during the surveillance. Also in these cases, the improvement of curve was correlated with the 
increased diameter of trachea seen on HRCT and bronchoscopy. All patients were asymptomatic. 
An example is reported in Figure 3. The remaining 10 patients (16.1%) presented aspecific 
distortion of the loop (false positive results).  
The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of visual analysis were 
63%; 83.9%; 63%; and 83.9%, and 77.5% respectively.         
 
Quantitative Analysis of Flow-volume curve 
The results are summarized in Table 2. 
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Among patients with recurrence (n=27), the MEF50%/MIF50%; FEV1/MEF, and FEV1/FEV0.5 
index were positive in 21 (77.8%); in 10 (37%); and in 8 cases (29%), respectively.  
Among patients without recurrence (n=62), the MEF50%/MIF50%; FEV1/MEF, and FEV1/FEV0.5 
index were negative in 49 (79%); in 30 (48%); and  in 23 cases (37%), respectively. 
 
Aggregate Criterion Of Flow-Volume Curve 
The aggregate criterion presented 17 positive results among 27 patients with recurrence and 49 
negative results among 62 patients without recurrence where Visual criterion and 
MEF50%/MIF50% (quantitative criterion with first highest-accuracy) were concordant. In the 
remaining cases with discordant results (10 among patients with recurrence and 13 among patients 
without recurrence), the aggregate criterion identified 5 of 10 patients with recurrence and 8 of 13 
patients without recurrence. The patients with or without recurrence were individuated according to 
above reported model: 
 
Aggregate Criterion= (visual criterion x MEF50%/MIF50%) + (FEV1/MEF) x (visual criterion + 
MEF50%/MIF50%) 
 
Considering all results, aggregate criterion was positive in 22 of 27 patients with recurrence 
(81.5%) and negative in 57 of 62 patients without recurrence (91.9%). The sensitivity, specificity, 
PPV, NPV, and accuracy were 81.5%; 91.9%; 81.5%; and 91.9%, and 88.8% respectively (Table 
2).  
 
Comparison among each individual criterion 
Multi-comparison test showed for sensitivity, specificity, PPV, NPV, and diagnostic accuracy a 
significant difference among Visual Analysis, MEF50%/MIF50%, FEV1/MEF, FEV1/FEV0.5 and 
Aggregate Criterion (p<0.0001). Post hoc test showed that (i) for sensitivity, the Aggregate 
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Criterion presented the higher value than others (p=0.0257), while FEV1/FEV0.5 had the lower 
value (p=0.0081); (ii) for specificity, the Aggregate Criterion (p=0.0003) and Visual Analysis 
(p=0.017) presented the higher value while FEV1/MEF (p=0.003) and FEV1/FEV0.5 (p<0.0001) 
the lower values; (iii) for PPV, the Aggregate Criterion presented the higher value (p=0.0003), 
while FEV1/FEV0.5 the lower value (p=0.0014); (iv) for NPV, the Aggregate Criterion presented 
the higher value (p=0.0259) while FEV1/MEF (p=0.0234) and FEV1/FEV0.5 (p=0.0005) the lower 
values; and (v) for Accuracy, the Aggregate Criterion (p<0.0001), Visual Analysis (p=0.0261) and 
MEF50%/MIF50%(p=0.0153) presented the higher values, while FEV1/MEF (p=0.0004) and 
FEV1/FEV0.5 (p<0.0001) the lower values. 
 
COMMENT 
Visual distortion of flow-volume curve is the most simple and used parameter to diagnose UAO. 
However, its diagnostic accuracy could be affected by the quality of flow-volume and variability of 
interpretations by physicians, thus several authors proposed quantitative indexes to overcome these 
limits [6-8,10-11]. However, no papers, before the present, have compared the diagnostic yield of 
visual, quantitative and aggregate criteria to detect recurrence during the surveillance of patients 
endoscopically treated for UAO.   
First, in agreement with previous papers [6,12-18], we found that visual analysis presented 
high specificity (84%), but low sensitivity (63%). Among patients with recurrence, it correctly 
detected the re-stenosis in 17 (63%) cases; after treatment, in the most of patients (88%) the loop 
was flattened  on inspiratory and expiratory phase (fixed stenosis) while in 56% of these cases it 
presented a flattening on inspiratory or expiratory phases (variable stenosis) before treatment.  The 
structural changes in stenotic scar as a result of dilation could explain these differences. Before 
dilation, the scar was less dense, and, thus, sensible to transmural forces that reduced the inspiratory 
flow rather than the expiratory flow in extrathoracic obstruction or vice versa in intrathoracic 
obstruction.  After dilation,  the formation of fixed scar produced a constant degree of airflow 
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limitation, resulting in a similar flattening on inspiratory and expiratory phase of the loop. 
Interestingly, in all cases a mild flattening was present in the early follow up before symptoms but it 
become more evident in relation to the progression of airway narrowing. Similarly, previous studies 
evaluated the flow volume curves generated by normal subjects breathing through progressively 
smaller artificial orifices and found that flow-volume curve distortion were reflective oforifices 
caliber [2]. In 10 cases without recurrence, we observed aspecific alterations of loop.  Sterner et al. 
[6] found that nearly 50% of 2.662 flow-volume curves presented similar aspecific inspiratory 
alterations, not associated with airway obstruction. These abnormalities could be due to different 
pre-existing disease as dysfunction of vocal folds, gastro-esophageal disease, Chronic Obstructive 
Pulmonary Disease (COPD), allergic rhinitis or flaccidity of anterior tracheal wall that reduced the 
inspiratory flow with consequent absence or truncation of inspiratory loop. In 10 of 27 (37%) 
patients with recurrence,  no flattening of the loop was present. Similarly, a normal loop was 
reported by Gamsu et al. [12] in 4 of 21 patients with stenosis. In theory, the low degree of stenosis 
(80% of these patients did not present severe symptoms of  UAO) could be insufficient to produce a 
marked limitation of flow rates.    
Second, in line with previous studies [3,8,14-18],  MEF50%/MIF50% ratio was the most 
sensitive quantitative parameter, and correctly identified 21 out of 27 (78%) patients with 
recurrence. In the most of fixed stenosis (16 of 21; 76%), the value of MEF50%/MIF50% ratio was 
between 1 and 1.5, since the fixed scar similarly reduced MIF50% and MEF50%.  In the remaining 
5 of 21 (24%) cases,  MEF50%/MIF50% value was > 1.5; in theory, normal tracheal segments 
between the lesion and thoracic outlet to negative intraluminal pressures tended to close the airway 
during inspiration [12], with consequent reduction of MIF50% rather than MEF50%. Das et al. [14] 
found higher sensitivity of MEF50%/MIF50% (85%) for detecting injury due to laryngotracheitis 
while Miller et al. [19] lower value of the same index (31%) for diagnosing UAO due to a goiter.  
However, the different etiologies of extrathoracic airflow obstruction between our and other series 
make difficult any comparison. FEV1/MEF ratio presented the second-highest accuracy; it   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
12 
 
correctly identified the recurrence in 10 of 27 (37%) cases while Empey et al. [7] found higher 
value. In theory, our low sensitivity could be due to the coexisting presence of COPD and 
emphysema that reduced FEV1 more than MEF [20]. Similarly, Gelb et al. [21] found that the 
improvement of loop after airway re-canalization was significantly masked by the obstruction of 
smaller airway in COPD and emphysematous patients. In theory, the FEV1/FEV1 0.5 index could 
be used to differentiate the flow-volume  curve abnormalities due to smaller airway obstruction 
from those due to UAO [22], but in our series it was unable to obtain this effect due to its low 
sensitivity and specificity.   
Third, in line with other papers [15,23,24] no significant difference was found between 
visual and quantitative criteria while aggregate criterion presented the best accuracy.Among 10 
patients with restenosis but without visual alteration of curve, 5 had positive aggregate criterion 
with consequent improvement of sensibility to 81.5%. Conversely, among 10 patients without 
restenosis but with visual alteration of curve, 5 had negative aggregate criterion with consequent 
improvement of specificity to 91.9%. In theory, the quantitative criteria used for generating  
aggregate criterion balanced the subjective variability of visual criterion. Similarly, Modrykamien 
et al. [18] found that the aggregate criterion increased the sensitivity to 69.4% for predicting UAO 
compared to that of quantitative and visual criteria alone. However, in Modrykamien’s study [18] 
visual and quantitative criteria presented lower sensitivity than that observed in our study. These 
differences could be explained by the high number of COPD patients who masked UAO on the 
flow-volume loop and/or by potential under diagnosis of UAO since not all patients performed 
endoscopy and/or imaging check [18]. 
 Since flow-volume curve presented a good correlation with radiological and endoscopic 
findings,  it could be an alternative option to CT scan and/or bronchoscopy in the surveillance of 
patients treated for UAO. Patients with normal follow-up loop could delay to perform CT and/or 
bronchoscopy; this strategy may be very useful in the settings where these procedures are least 
available i.e. rural settings, far distance for CT scan centers and specialists. Yet, the reduction of CT 
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scan done reduced the cancer risk related to radiation exposure and health care cost considering that 
the cost of flow-volume curve is three folds lower than that of CT (40 Euros versus 150 Euros).  In 
line with this tendency, Brenner and Hall [25] analyzed the current trend to increased use of CT 
scan imaging and reported that one third of CT scan could be avoided or replaced with a different 
diagnostic tool. Conversely, in patients with early modification of follow-up flow volume curve, the 
measurements during the surveillance should be implemented (i.e. every 4-6 weeks). Despite 
patients do not come to endoscopic intervention until they have symptoms, however the early 
diagnosis of re-stenosis before symptoms could avoid an emergent and challenging treatment 
considering that exertional dyspnea occurs when the airway diameter is reduced to about 8 mm 
while resting dyspnea and stridor at a diameter of 5 mm [26].  
Obviously, our results should be evaluated with cautious due to the retrospective nature of 
the study, the lack of a standardized protocol, and the measurements of curve performed and 
analyzed by different technicians and physicians being a multicenter study. In conclusion, Flow-
volume curve is a simple and non-invasive method to follow-up patients treated for UAO and its 
routine use could reduce the number of follow-up CT scan, and bronchoscopy done in patients with 
normal loops. However, prospective and larger studies are needed to confirm our impressions.     
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Table 1. Study population (n=89) 
 
Variables Number (%) 
Age 73±6.9 
Sex (M/F) 55 (62%)/34(38%) 
Etiology of stenosis 
• Idiopathic 
• Post-intubation 
• Post-tracheostomy 
 
  3 (4%) 
51 (57%) 
35 (39%) 
Comorbidities contraindicating surgery  
• Cardiac 
• Cerebral  
• Respiratory 
• Drug Abuse 
 
39 (44%) 
28 (31%) 
20 (22%) 
2 (3%) 
Characteristics of the stenosis 
• Distance from vocal folds (mm) 
• Diameter (mm) 
• Length (mm) 
 
27±3.9 
6±3.7 
8±1.3 
Diameter after dilation 14±6.7 
Recurrence of stenosis 27 (30%) 
Treatment of recurrence 
• Dilation alone 
• Stent insertion 
• Surgery 
 
15 (55%) 
10 (37%) 
2 (8%) 
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Table 2. Diagnostic yield of flow-volume curve criteria 
 
 
Abbreviations: MEF50%/MIF50%=Maximal Expiratory Flow Rate At 50% Of The Vital 
Capacity/ Maximal Inspiratory Flow Rate At 50% Of The Vital Capacity; FEV1/MEF=Forced 
Expiratory Volume in the first 1 second/Maximal Expiratory flow; FEV1/FEV0.5=Forced 
Expiratory Volume In The First 1 Second/ Forced Expiratory Volume In The First 0.5 second 
 
  
Variable Sensitivity Specificity PPV NPV Diagnostic 
accuracy 
Visual Analysis 63.0% 
(42.3-80.3) 
83.9%  
(72.3-91.9) 
63.0% 
(44.9-75.9) 
83.9% 
(76-89.7) 
77.5%  
(67.2-85.5) 
MEF50%/MIF50%  
Miller et Hyatt index [3] 
77.8% 
(57.7-91.3) 
79.0% 
(66.8-88.3) 
61.8% 
(48.4-72.8) 
89.1% 
(80.2-94.4) 
78.7% 
(68.5-86.5) 
FEV1/MEF   
Empey index [7] 
37.0% 
(19.4-57.6) 
48.4% 
(35.4-61.4) 
23.8% 
(15-34.7) 
63.8% 
(54.9-72.5) 
44.9% 
(34.5-55.8) 
FEV1/FEV0.5  
Rotman index [8] 
29.6% 
(13.7-25.1) 
37.1% 
(25.1-50.3) 
17.0% 
(9.8-27.1) 
54.8% 
(45-64.8) 
34.8% 
(25.2-45.6) 
Aggregate Criterion 81.5% 
(61.9-93.7) 
91.9% 
(82.1-97.3) 
81.5% 
(64.7-91) 
91.9% 
(83.9-96.2) 
88.8% 
(79.9-94.5) 
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FIGURE LEGENDS 
 
 
Figure 1.  Different shape of flow-volume loops before dilation. (A) Flattening on inspiratory and 
expiratory phases of the loop (fixed stenosis); B) Flattening on expiratory phase of the loop 
(variable intrathoracic stenosis); C) Flattening on inspiratory phase of the loop (variable 
extrathoracic stenosis); Aspecific flow-volume loops: D) Biphasic expiratory loop; E) Truncate 
inspiratory loop;  F) Absence of inspiratory loop.   
 
Figure 2. Before endoscopic dilation, it was well evident a flattening on the inspiratory and 
expiratory phase of the loop (fixed stenosis). One month after dilation, the flow-volume curve 
showed a marked improvement in the first month.  A flattening was then present 5 months later and 
become more marked 7 months later, concurrent with the reduction of airway diameter seen on 
High Resolution Computed Tomography (HRCT) and endoscopy and with the onset of symptoms. 
Black arrows showed the progression of the scar during the follow-up that caused the re-stenosis.       
 
Figure 3. Before endoscopic dilation, it was evident a flattening on the expiratory phase of the loop 
(variable intrathoracic stenosis). After dilation, the expiratory loop improved, concurrent with the 
increase of airway diameter seen on HRCT and endoscopy and with the lack of symptoms; these 
results were maintained during the entire follow-up. Black arrows showed the cicatrization of the 
scar, preserving normal airway patency.   
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